Psyched: Veterans & Psychedelics, $100M IPO, Cybin’s $64M Offering, Worldwide Events & More
Veterans Day: Can Psychedelic Treatment Help Stem PTSD-Related Suicides Among Veterans?
Marijuana Stock Movers For November 10, 2023
GAINERS: GrowLife (OTC:PHOT) shares closed up 400.00% at $0.01 Affinor Growers (OTC:RSSFF) shares closed up 146.39% at $0.02…
Cannabis Profit Harvest: Verano’s Leaders Talk Q3 Success
Explore Verano's Q3 growth & investment strategies with Darren Weiss & Aaron Miles on Benzinga Cannabis Insider's latest episode.
Cybin Launches Five-Day Units Offering For Up To $64M, Suspends Prior LPC Funding Deal
Clinical-stage psychedelics biotech Cybin Inc. (NYSE: CYBN) has announced a new underwritten offering of 66.66 million units to one of its largest institutional shareholders as well as new institutional investors.
Needham Analysts Laud This Cannabis Giant’s Growth, Eyeing Solid 4Q For TerrAscend
TerrAscend Corp. (OTC: TSNDF) displayed significant growth in the third quarter, with expectations of maintaining this momentum into the fourth quarter. This growth is attributed primarily to the adult-use conversion in Maryland and increased efficiency, leading to an improvement in EBITDA margins.
Mary Jones Cannabis Sodas’ Revenue Drop, Q3 Was ‘More Challenging Than Expected,’ CEO Says
Jones Soda Co. (CSE: JSDA) (OTCQB: JSDA) reported its financial results on Thursday for the third quarter ended September 30, 2023.
Analyst Weighs In On Cannabis Giant Curaleaf’s Q3 Results
Curaleaf Holdings Inc. (OTC: CURLF), a leader in the global cannabis market, recently released its Q3 2023 earnings report, revealing complex industry dynamics.
Analysts Bullish On Cannabis Co. TerrAscend Post-Earnings: Raised Targets And Upgraded Ratings
In the wake of TerrAscend Corp. (OTC: TSNDF)'s impressive third-quarter earnings, several analysts have revised their ratings and price targets, signaling renewed optimism for the cannabis company's prospects.
Blooming: Flora Growth’s First Profitable Quarter Amid Strategic Shifts
Discover Flora Growth's strategic rise to its first profitable quarter with a 78% revenue increase in Q3 2023.
Restructuring Efforts Yield Results For Cannabis-Focused Agriculture Equipment Maker Despite 27% YoY Revenue Drop In Q3
Hydrofarm Holdings Group, Inc. (NASDAQ: HYFM) announced its financial results on Thursday for the third quarter ended Sept. 30, 2023, revealing a nearly 27% year-over-year net sales drop to $54.2 million.